Primary Site >> Esophagus Cancer
Gene >> IMP3
|
|
|---|---|
|
Ref: Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy. PMID: 17784873 |
Ref: Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens. PMID: 22776426 |